Screener
ADMA Biologics ADMA Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
| Line item | Three Months ended June 30, 2026 | Three Months ended June 30, 2025 | Six Months ended June 30, 2026 | Six Months ended June 30, 2025 |
|---|---|---|---|---|
| (In thousands, except share and per share data) | ||||
| REVENUES | $$124,395 | $121,984 | $238,888 | 236,786 |
| Cost of product revenue | 38,118 | 54,757 | 71,861 | 108,463 |
| Gross profit | 86,277 | 67,227 | 167,027 | 128,323 |
| OPERATING EXPENSES: | ||||
| Research and development | 6,014 | 1,031 | 8,611 | 1,858 |
| Plasma center operating expenses | 1,026 | 1,152 | 2,088 | 2,438 |
| Amortization of intangible assets | 55 | 32 | 110 | 57 |
Item 1. Financial Statements.
FAQ
- What is ADMA Biologics's total cost of revenue?
- ADMA Biologics (ADMA) reported total cost of revenue of $38.12M in Q2 2026.
- How has ADMA Biologics's total cost of revenue changed year-over-year?
- ADMA Biologics's total cost of revenue decreased by 30.4% year-over-year, from $54.76M to $38.12M.
- What is the long-term trend for ADMA Biologics's total cost of revenue?
- Over 4 years (2021 to 2025), ADMA Biologics's total cost of revenue has grown at a 28.5% compound annual growth rate (CAGR), from $79.77M to $217.41M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about ADMA Biologics's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude